Opko Health, Inc. (NASDAQ:OPK)

CAPS Rating: 2 out of 5

Caps

How do you think OPK will perform against the market?

Add Stock to CAPS Watchlist

All Players

251 Outperform
30 Underperform
 

All-Star Players

22 Outperform
12 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top OPK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TheBigFinn (< 20)
Submitted October 04, 2015

Their 4KScore Test accurately predicts prostate cancer risk has received insurance classificationTheir drug Rayaldee with a +$10B market potential completed phase 3 trials and an NDA was submitted to to the FDA last May we approval expect in… More

allstar31 (99.92)
Submitted September 13, 2014

Uses known stock promoter Redchip.com. Is a pump and dump scam.

OPK VS S&P 500 (SPY)

Fools bullish on OPK are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about OPK.

Recs

0
Member Avatar pchop12316 (91.31) Submitted: 9/9/2018 1:08:00 PM : Underperform Start Price: $3.79 OPK Score: -13.66

likely to keep declining

Recs

0
Member Avatar TMFBiologyFool (84.97) Submitted: 7/12/2018 5:30:48 PM : Underperform Start Price: $6.23 OPK Score: +35.25

Up substantially on no apparent news.

Recs

0
Member Avatar SaintCroix (99.22) Submitted: 2/16/2018 6:08:24 PM : Outperform Start Price: $3.88 OPK Score: +0.73

I'm fascinated by Phillip Frost, the biotech billionaire who loves to invest in micro-cap stocks. He and his team have a history of using reverse-mergers to introduce start-ups into the public markets. Presumably they want to avoid all the regulatory crap that goes along with an IPO. Not to mention banks taking a good chunk of your equity. I feel like Frost is one of the good guys.

I think it's a good idea to follow Frost's investments in CAPS. He did not make his billions in biotech--he made his billions in generic drugs--but he's a medical doctor and a financial whiz. It might be unconventional to bring start-ups into the public markets the way he does. But if you pay attention to his investments, you have an opportunity to invest like a VC, at VC prices.

And I love that he keeps buying shares of his own stock! I expect some short-term volatility, but this is an interesting healthcare company. Outperform.

Leaderboard

Find the members with the highest scoring picks in OPK.

Score Leader

romanson3625

romanson3625 (< 20) Score: +236.00

The Score Leader is the player with the highest score across all their picks in OPK.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. superdealsonly 31.21 2/4/2013 Underperform 5Y $6.81 -36.56% +94.25% +130.81 0 Comment
MisterCHW 99.94 1/29/2013 Underperform 5Y $6.80 -36.47% +93.94% +130.41 0 Comment
iniesta13 53.49 3/25/2013 Underperform 1Y $7.61 -43.23% +87.16% +130.39 0 Comment
tortoisetriguy 81.66 2/14/2013 Underperform 5Y $6.83 -36.75% +92.49% +129.24 0 Comment
XMFConnor 95.64 5/16/2012 Underperform 5Y $4.62 -6.49% +118.00% +124.49 0 Comment
gatzbp 62.58 7/6/2012 Underperform 3Y $4.70 -8.09% +115.73% +123.82 1 Comment
Quaker08 29.93 12/12/2013 Underperform 5Y $9.74 -55.62% +63.91% +119.53 0 Comment
Covestor 63.15 3/14/2011 Underperform NS $3.76 +14.89% +125.04% +110.15 1 Comment
bpark3538 < 20 3/6/2014 Underperform 3Y $9.45 -54.29% +55.14% +109.43 0 Comment
stratisticalarb 97.98 4/26/2011 Underperform 1Y $3.99 +8.26% +116.67% +108.42 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
Anonymous331 35.02 6/3/2016 Outperform 5Y $10.44 -58.63% +39.09% -97.72 0 Comment
TrackOppenheimer 71.42 3/14/2014 Outperform NS $9.61 -55.05% +58.00% -113.05 0 Comment
TrackJimCramer 85.64 10/13/2011 Outperform 3W $5.04 -14.29% +138.22% -152.51 0 Comment
TrackLadenburg < 20 7/14/2011 Outperform NS $4.18 +3.35% +120.92% -117.57 0 Comment

Featured Broker Partners


Advertisement